Cross-platform Q-TOF validation of global exo-metabolomic analysis: application to human glioblastoma cells treated with the standard PI 3-Kinase inhibitor LY294002.

Source:http://linkedlifedata.com/resource/pubmed/id/19101213

J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 2009 May 1 877 13 1352-8

Download in:

View as

Triples

General Info

PMID
19101213